Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Avono Health vs MDLive

Avono Health
Graded #361

Lower grade

vs+0.09999999999999432
MDLive
Graded #358

Higher grade

The verdict

MDLive takes it — 58.8/100 to 58.7/100, but only just.

MDLive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MDLive (an Evernorth/Cigna company) is a large telehealth provider offering urgent care, primary care, dermatology and behavioral health. Avono Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMDLive +15
30
45
Dose & formulationAvono Health +22
75
53
Clinical oversightMDLive +5
80
85
Labs & monitoringMDLive +1
53
54
FulfillmentAvono Health +9
71
62
Contract termsMDLive +8
47
55
Avono Health · left barMDLive · right bar

The numbers

MetricAvono HealthMDLive
WeighScore58.7/10058.8/100
GradeCC
Scorecard rank#361#358
Semaglutide$269/mo (compounded)Not disclosed
Tirzepatide$349/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Avono Health

Graded #361 · C

Strengths

  • Transparent tiered pricing from $179/mo (microdose semaglutide injection)
  • Full compounded range — semaglutide and tirzepatide, injection and oral, microdose and standard
  • Free and discreet shipping; 24/7/365 messaging support; 100% online
  • US-licensed clinicians and pharmacies; bundle discounts at 3/6/12 months

Where it loses points

  • Medications are compounded, not FDA-approved brand-name
  • Compounding pharmacy not publicly named
  • State availability not published
  • Newer brand with limited independent review history
MDLive

Graded #358 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s including Wegovy and Zepbound
  • Covered through insurance and employer benefits for 50M-plus people
  • Board-certified physicians averaging about 15 years of experience
  • Part of Evernorth/Cigna, a large established healthcare organization
  • Offers full primary care, not just a single weight-loss funnel

Where it loses points

  • GLP-1s only at clinician discretion in a Primary Care routine visit
  • Anti-obesity meds not available in FL, LA, MS or NJ
  • Distributed mainly via insurers and employers; cost varies by plan
  • No transparent published monthly cash price for GLP-1 care

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard